MHLW Report Finds No Relations Between Tamiflu Use And Abnormal Behavior
This article was originally published in PharmAsia News
A safety team at Japan's Ministry of Health, Labor and Welfare reported June 17 that clinical tests found no evidence that taking Chugai Pharmaceutical's flu drug Tamiflu (oseltamivir phosphate) affected electrocardiograms and sleep patterns. The clinical report also stated that there was no evidence showing relation between the administration of Tamiflu and sudden death or abnormal behavior. The team conducted electrocardiograms on 11 healthy males between the ages of 20-51. The team also conducted researches on brain waves of 31 males aged between 20-24 when sleeping and found no abnormality in brain waves after taking Tamiflu. (Click here for more - Japanese language
You may also be interested in...
The proposed rule from the US HHS that would require its agencies to review all regulations every 10 years could distract an incoming Biden administration from the COVID-19 pandemic and will “wreak havoc” on Medicare, a senior policy analyst for the Center on Budget and Policy Priorities says.
The pharmacy will be ready to begin COVID-19 vaccinations 48 hours after receiving the vaccine, Merlo said, outlining plans for a mass vaccination effort that will include online appointments.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.